157 related articles for article (PubMed ID: 30515639)
1. Is Integrin Subunit Alpha 2 Expression a Prognostic Factor for Liver Carcinoma? A Validation Experiment Based on Bioinformatics Analysis.
Zhang L; Huang Y; Ling J; Zhuo W; Yu Z; Luo Y; Zhu Y
Pathol Oncol Res; 2019 Oct; 25(4):1545-1552. PubMed ID: 30515639
[TBL] [Abstract][Full Text] [Related]
2. Identification and Characterization of Cadmium-Related Genes in Liver Carcinoma.
Zhang L; Huang Y; Zhu Y; Yu Z; Shao M; Luo Y
Biol Trace Elem Res; 2018 Apr; 182(2):238-247. PubMed ID: 28791617
[TBL] [Abstract][Full Text] [Related]
3. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
4. ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis.
Islam S; Kitagawa T; Baron B; Abiko Y; Chiba I; Kuramitsu Y
Sci Rep; 2021 May; 11(1):10563. PubMed ID: 34007003
[TBL] [Abstract][Full Text] [Related]
5. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.
Wang J; Tian Y; Chen H; Li H; Zheng S
Mol Med Rep; 2018 Jun; 17(6):8153-8160. PubMed ID: 29658607
[TBL] [Abstract][Full Text] [Related]
6. Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy.
Zhang YP; Bao ZW; Wu JB; Chen YH; Chen JR; Xie HY; Zhou L; Wu J; Zheng SS
Technol Cancer Res Treat; 2020; 19():1533033820944274. PubMed ID: 32715976
[TBL] [Abstract][Full Text] [Related]
7. ADAR1 p110 Enhances Adhesion of Tumor Cells to Extracellular Matrix in Hepatocellular Carcinoma via Up-Regulating ITGA2 Expression.
Yu J; Zhang C; Yu Q; Yu H; Zhang B
Med Sci Monit; 2019 Feb; 25():1469-1479. PubMed ID: 30798327
[TBL] [Abstract][Full Text] [Related]
8. Screening and function analysis of hub genes and pathways in hepatocellular carcinoma via bioinformatics approaches.
Zhang L; Huang Y; Ling J; Zhuo W; Yu Z; Shao M; Luo Y; Zhu Y
Cancer Biomark; 2018; 22(3):511-521. PubMed ID: 29843214
[TBL] [Abstract][Full Text] [Related]
9. Analysis of potential key genes in very early hepatocellular carcinoma.
Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
[TBL] [Abstract][Full Text] [Related]
10. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
Wan Z; Zhang X; Luo Y; Zhao B
Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
[No Abstract] [Full Text] [Related]
11. Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.
Zhang Q; Sun S; Zhu C; Zheng Y; Cai Q; Liang X; Xie H; Zhou J
Mol Med Rep; 2019 Apr; 19(4):2479-2488. PubMed ID: 30720105
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of sexual dimorphism‑linked gene expression profile in hepatocellular carcinoma.
Wu Y; Yao N; Feng Y; Tian Z; Yang Y; Zhao Y
Oncol Rep; 2019 Sep; 42(3):937-952. PubMed ID: 31322260
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma.
Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL
Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575
[TBL] [Abstract][Full Text] [Related]
14. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.
Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ
BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of SLC7A11: a novel oncogene and an indicator of unfavorable prognosis for liver carcinoma.
Zhang L; Huang Y; Ling J; Zhuo W; Yu Z; Luo Y; Zhu Y
Future Oncol; 2018 Apr; 14(10):927-936. PubMed ID: 29528250
[TBL] [Abstract][Full Text] [Related]
16. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
17. Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway.
Ren D; Zhao J; Sun Y; Li D; Meng Z; Wang B; Fan P; Liu Z; Jin X; Wu H
J Exp Clin Cancer Res; 2019 Dec; 38(1):485. PubMed ID: 31818309
[TBL] [Abstract][Full Text] [Related]
18. ITGA2 as a prognostic factor of glioma promotes GSCs invasion and EMT by activating STAT3 phosphorylation.
Zhang J; Li R; Zhang H; Wang S; Zhao Y
Carcinogenesis; 2024 Apr; 45(4):235-246. PubMed ID: 38142122
[TBL] [Abstract][Full Text] [Related]
19. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
20. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
